Isoniazid / rifampin Pregnancy and Breastfeeding Warnings
Isoniazid / rifampin Pregnancy Warnings
Isoniazid-rifampin has not been formally assigned to a pregnancy categoy by the FDA. Isoniazid-rifampin is only recommended for use during pregnancy when benefit outweighs risk. Isoniazid has been assigned to a pregnancy category C by the FDA. Animal studies have revealed evidence of embryolethality. There are no controlled data in human pregnancy; however, isoniazid is known to cross the placental barrier. Rifampin has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of embryotoxicity and teratogenicity. There are no controlled data in human pregnancy; however, rifampin has been reported to cross the placental barrier and appear in cord blood. Isolated cases of fetal malformations have been reported. Postnatal hemorrhages in the mother and infant have been associated with the use of rifampin during the last few weeks of pregnancy, and administration of vitamin K may be indicated.
Isoniazid / rifampin Breastfeeding Warnings
Isoniazid and rifampin are excreted into human milk. Adverse effects in the nursing infant due to isoniazid are unlikely. The effects of rifampin in the nursing infant are unknown. Isoniazid is considered compatible with breast-feeding by the manufacturer; however, the manufacturer of rifampin recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. Isoniazid and rifampin are considered compatible with breast-feeding by the American Academy of Pediatrics.
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.